Keros Therapeutics, Inc. Common Stock
$11.19
Market Cap
$225.24M
Shares Outstanding
19.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 8, 2020
Round Lot
100
Locale
US
Day Open
$11.32
Day High
$11.40
Day Low
$11.10
Volume
302.5K
VWAP
$11.20
Prev Close
$11.36
Transactions
--
Acc. Volume
--
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Keros Therapeutics, Inc. Common Stock (KROS) closed the 2026-09-18 session at $11.19, down 1.50% versus the previous close (-0.17). The stock opened at $11.32 and traded between $11.10 and $11.40 during that session. Session trading volume was 302K shares. The volume-weighted average price (VWAP) is $11.20.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Keros Therapeutics, Inc. Common Stock has a market capitalization of $225.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. KROS is listed on the XNAS exchange. The company employs approximately 92 people. Keros Therapeutics, Inc. Common Stock is headquartered in LEXINGTON, MA. The recorded listing date is 2020-04-08.
On this page you can find market KROS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.